Long-Term Monitoring and Carney Complex Surveillance
At a Glance
PPNAD does not automatically mean Carney Complex, but it warrants individualized assessment and long-term follow-up. Surveillance may include heart, pituitary, thyroid, skin, genetic, and bone-density checks, with ongoing hormone replacement after bilateral adrenalectomy.
Because PPNAD is so closely linked to Carney Complex (CNC), a diagnosis of the adrenal condition is often just the beginning of a lifelong monitoring relationship with your medical team. Carney Complex is a multi-system syndrome, meaning it can affect various organs over time [1][2]. With proper surveillance, most of these manifestations can be managed effectively, allowing for a high quality of life [3][4].
Personalized Carney Complex Surveillance
A diagnosis of PPNAD alone does not automatically mean you have Carney Complex. Your care team will usually conduct a baseline assessment. Based on this, they will create an individualized follow-up plan. The following schedule represents an example approach for confirmed or suspected Carney Complex [2][5]:
| Organ/System | Screening Method | Example Frequency |
|---|---|---|
| Heart | Echocardiogram (Ultrasound of the heart) | Annually (when no myxoma is known); Every 6 months (for prior/current myxoma or specialist-defined higher risk) [2][6] |
| Pituitary | IGF-1 blood test (checks for growth hormone excess) | Annually (starting at puberty) [5][7] |
| Thyroid | Thyroid Ultrasound | Annually or as clinically indicated [8] |
| Testicles | Physical exam and Testicular Ultrasound | Annually or for new lumps/asymmetry [9][10] |
| Skin | Full-body dermatologic examination | Annually or for new/changing spots [11] |
The most critical of these is the heart ultrasound (echocardiogram). This is because people with Carney Complex are at risk for cardiac myxomas—non-cancerous but potentially dangerous tumors that can grow inside the heart chambers [2]. These tumors can develop or recur quickly [6]. New cardiac symptoms, such as shortness of breath or palpitations, require prompt medical evaluation even if the next scheduled echocardiogram is distant.
Genetic Counseling and Cascade Testing
If genetic testing confirms you carry a pathogenic germline PRKAR1A variant, Carney Complex is inherited in an autosomal dominant pattern. This means there is a 50% chance of passing the variant to each child [12][13]. (This 50% transmission does not automatically apply from a PPNAD diagnosis alone, a negative test, or a variant of uncertain significance).
If a pathogenic variant is identified, cascade genetic screening should be arranged through genetic counseling for first-degree relatives (parents, siblings, and children) [14][15]. This is important because relatives may have “silent” versions of the disease [14]. Relatives with a positive result should receive an individualized surveillance plan rather than automatically being assigned an identical schedule [14][7].
Life After Adrenalectomy: The Long View
For those who have had a bilateral adrenalectomy, the long-term outlook is generally positive, though adjustment takes time. Once the excess cortisol is removed, many of the most taxing symptoms of Cushing’s syndrome begin to reverse:
- Physical Recovery: Most patients experience significant weight loss, improvements in high blood pressure, and a return of normal energy levels, though recovery from muscle weakness and mood changes may take months or longer. Bilateral adrenalectomy cures the cortisol overproduction, not the underlying Carney Complex [3][16]. In children, a “catch-up” growth spurt is often seen as height velocity improves [4].
- Bone and Mental Health: Because high cortisol is damaging to bones and mood, long-term monitoring should include baseline and periodic DXA scans (frequency determined universally by your doctor based on baseline results) to check for bone density, and assessments of mental well-being [17][18].
Success in the long term depends on strict adherence to your daily hormone replacement medications and staying diligent with your individualized Carney Complex surveillance [19][20].
Common questions in this guide
Does having PPNAD mean that I have Carney Complex?
What tests are usually part of Carney Complex surveillance?
Why is heart monitoring important in Carney Complex?
What does a PRKAR1A result mean for my family?
What should I expect after bilateral adrenalectomy for PPNAD?
How is bone health monitored after surgery for PPNAD?
How can I keep up with lifelong PPNAD and Carney Complex follow-up?
Get notified when new evidence is published on pigmented nodular adrenocortical disease, primary, 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (20)
- 1
The clinical characteristics and pathogenic variants of primary pigmented nodular adrenocortical disease in 210 patients: a systematic review.
Sun J, Ding L, He L, et al.
Frontiers in endocrinology 2024; (15()):1356870 doi:10.3389/fendo.2024.1356870.
PMID: 39006359 - 2
Frequency and Incidence of Carney Complex Manifestations: A Prospective Multicenter Study With a Three-Year Follow-Up.
Espiard S, Vantyghem MC, Assié G, et al.
The Journal of clinical endocrinology and metabolism 2020; (105(3)) doi:10.1210/clinem/dgaa002.
PMID: 31912137 - 3
Cushing's syndrome due to primary pigmented nodular adrenal disease in two brothers with Carney complex.
Attri B, Aggarwal A, Mattoo S, Kulshreshtha B
Pediatric endocrinology, diabetes, and metabolism 2020; (26(3)):155-158 doi:10.5114/pedm.2020.95625.
PMID: 32901471 - 4
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE (PPNAD) PRESENTING AS CUSHING SYNDROME IN A CHILD AND REVIEW OF LITERATURE.
Bavadiya G, Roy A, Sarkar KK, et al.
Acta endocrinologica (Bucharest, Romania : 2005) 2020; (16(3)):362-365 doi:10.4183/aeb.2020.362.
PMID: 33363661 - 5
The Spectrum of GH Excess in Carney Complex and Genotype-phenotype Correlations.
Tatsi C, Pitsava G, Faucz FR, et al.
The Journal of clinical endocrinology and metabolism 2025; (110(3)):e694-e702 doi:10.1210/clinem/dgae253.
PMID: 38626285 - 6
Recurrent left atrial myxoma in Carney complex: A case report of a familial pedigree.
Wang L, Wang Q, Zhou Y, et al.
Medicine 2018; (97(12)):e0247 doi:10.1097/MD.0000000000010247.
PMID: 29561454 - 7
Cushing's syndrome and early growth hormone hypersecretion in a child with Carney complex: a case report.
Pietropaolo G, Festa A, Rivetti G, et al.
Frontiers in endocrinology 2026; (17()):1843310 doi:10.3389/fendo.2026.1843310.
PMID: 42445874 - 8
Carney complex: a case with thyroid follicular adenoma without a PRKAR1A mutation.
Hattori S, Yamane Y, Shimomura R, et al.
Surgical case reports 2018; (4(1)):34 doi:10.1186/s40792-018-0438-z.
PMID: 29666959 - 9
A urologic manifestation of carney complex: Bilateral Sertoli tumors and scrotal myxoma in an adolescent male.
Walter E, Wolfe A, Yu Z, Rensing A
Urology case reports 2026; (65()):103383 doi:10.1016/j.eucr.2026.103383.
PMID: 41768348 - 10
A 14-Year-Old Saudi Boy with Gynecomastia, Cushing Syndrome, Large-Cell Calcifying Sertoli Cell Tumor of the Testis, and Carney Complex.
Alruwaili TK, Alkanhal KI, AlShoomi AM, et al.
The American journal of case reports 2022; (23()):e937404 doi:10.12659/AJCR.937404.
PMID: 36573035 - 11
Dermatological and endocrine elements in Carney complex (Review).
Sandru F, Dumitrascu MC, Petca A, et al.
Experimental and therapeutic medicine 2021; (22(5)):1313 doi:10.3892/etm.2021.10748.
PMID: 34630667 - 12
Fatal Carney Complex in Siblings Due to De Novo Large Gene Deletion.
Stelmachowska-Banas M, Zgliczynski W, Tutka P, et al.
The Journal of clinical endocrinology and metabolism 2017; (102(11)):3924-3927 doi:10.1210/jc.2017-01045.
PMID: 28973408 - 13
Malignant psammomatous melanotic schwannoma in a patient with Carney complex associated with a novel variant in the PRKAR1A gene.
Vázquez Ares MJ, Rolón C, Mercado G
Cancer genetics 2026; (304-305()):126-129 doi:10.1016/j.cancergen.2026.04.005.
PMID: 42033847 - 14
Integrated clinical-genetic-pathological analysis expands the phenotypic and molecular spectrum of PPNAD across carney complex and isolated forms.
Kuhn AW, Lerario AM, Charchar HL, et al.
European journal of endocrinology 2026; (195(2)):217-228 doi:10.1093/ejendo/lvag137.
PMID: 42543523 - 15
Primary pigmented nodular adrenocortical disease (PPNAD): single centre experience.
Memon SS, Thakkar K, Patil V, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(4)):391-397.
PMID: 30875328 - 16
Outcomes of Bilateral Adrenalectomy in Cushing's Syndrome.
Nagendra L, Bhavani N, Pavithran PV, et al.
Indian journal of endocrinology and metabolism 2019; (23(2)):193-197 doi:10.4103/ijem.IJEM_654_18.
PMID: 31161102 - 17
Cushing Syndrome in Childhood.
Parish A, Cheung C, Ryabets-Lienhard A, et al.
Pediatrics in review 2024; (45(1)):14-25 doi:10.1542/pir.2022-005732.
PMID: 38161162 - 18
A novel approach to intraoperative diagnosis of primary pigmented nodular adrenocortical disease.
Wijesekara Pathirana NS, Udayakumara H, Banagala ASK, et al.
Endocrinology, diabetes & metabolism case reports 2025; (2025(1)).
PMID: 39932060 - 19
Adrenal Cushing's syndrome in children.
Guarnotta V, Emanuele F, Salzillo R, Giordano C
Frontiers in endocrinology 2023; (14()):1329082 doi:10.3389/fendo.2023.1329082.
PMID: 38192416 - 20
PRKAR1A-negative familial Cushing's syndrome: two case reports.
Lim LL, Kitan N, Paramasivam SS, et al.
Journal of medical case reports 2015; (9()):277 doi:10.1186/s13256-015-0757-7.
PMID: 26619967
This page is for informational purposes only and does not constitute medical advice. Your endocrinologist, genetic counselor, and other specialists should tailor Carney Complex surveillance and hormone replacement to your or your child’s needs.